Eli Lilly and Company · 1 day ago
Director - Mass Spectrometry-based Biomarker Discovery - Neuroscience
Boston, MA
Full-time
Onsite
Lead/Staff, Director/Executive
$184K/yr - $321K/yr
5+ years expEli Lilly and Company is a global healthcare leader dedicated to improving lives through innovative therapies. The Director of Mass Spectrometry-based Biomarker Discovery will lead the development and validation of biomarker assays for neurodegenerative diseases, guiding strategic direction and technical execution within the Neuroscience Research team.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Development and validation of novel mass spectrometry-based assays for early- and late-phase clinical trials in neurodegenerative diseases, including Alzheimer’s, Parkinson’s, ALS, and rare brain disorders
Work with project team leads, and mentor junior associates to design and execute in vitro experiments to support both the preclinical and clinical characterization and evaluation of therapeutic molecules through biomarker assay development
Assist with the planning and execution of method development, optimization, and sample analyses, working with internal and external partners to coordinate readouts for complex studies
Implement assay validation procedures to deliver high performance biomarker assays for preclinical and clinical sample analyses
Serve as a scientific and technical expert for in-house and outsourced biomarker discovery efforts, establishing experimental study design and analytical strategies
Collaborate cross-functionally with internal stakeholders (medical, operations, statistics, regulatory) and external partners (CROs, academic institutions) to ensure biomarker validation and successful integration into clinical programs
Communicate findings through presentations, publications, and strategic discussions, reinforcing Lilly’s leadership in biomarker innovation
Qualification
Required
PhD in Neuroscience, Biochemistry or a related scientific field
5+ years of industry, academic, or postdoctoral experience in biomarker development
Recognized expertise in mass spectrometry-based assays for brain diseases
Preferred
Deep understanding of the mass spectrometry technology and instrumentation
Mass spectrometry-based assay development and validation for biomarker applications in clinical trials
Technically skilled to independently execute advanced mass spectrometry-based studies
Proven leadership in managing and mentoring biomarker research teams in academic or industry settings
Strong strategic thinking, problem-solving abilities, and the ability to drive innovation in biomarker discovery
Excellent communication, collaboration, and negotiation skills to influence both internal and external stakeholders
Demonstrated ability to translate scientific insights into impactful clinical applications
Benefits
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
Business Standard India
2026-01-14
2026-01-14
pharmaphorum
2026-01-14
Company data provided by crunchbase